Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells

PURPOSE: Dipeptidyl peptidase-4 (DPP-4) inhibitors increase endothelial progenitor cells (EPCs) in peripheral blood circulation. However, the underlying mechanisms and effects on vascular endothelial function remain unclear. We evaluated whether the DPP-4 inhibitor teneligliptin increases circulatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Akashi, Naoyuki, Umemoto, Tomio, Yamada, Hodaka, Fujiwara, Takayuki, Yamamoto, Kei, Taniguchi, Yousuke, Sakakura, Kenichi, Wada, Hiroshi, Momomura, Shin-ichi, Fujita, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108873/
https://www.ncbi.nlm.nih.gov/pubmed/37077576
http://dx.doi.org/10.2147/DMSO.S403125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108873/
https://www.ncbi.nlm.nih.gov/pubmed/37077576
http://dx.doi.org/10.2147/DMSO.S403125

Ejemplares similares